From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents

被引：0
|
作者：
Caprio, Massimiliano [1 ,2 ]
Vitale, Cristiana [3 ]
Rosano, Giuseppe M. C. [3 ]
机构：
[1] IRCCS San Raffaele Pisana, Lab Cardiovasc Endocrinol, Rome, Italy
[2] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, Rome, Italy
[3] IRCCS San Raffaele, Dept Cardiovasc & Resp Sci, Rome, Italy
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2021年 / 7卷 / 02期
关键词：
ACUTE MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; INSULIN-GLUCOSE; MORTALITY; LIRAGLUTIDE; PREVALENCE; OUTCOMES; RISK;
D O I：
10.1093/ehjcvp/pvaa019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：83 / 85
页数：3
相关论文
共 50 条
  • [1] Glucose-lowering treatment in cardiovascular and peripheral artery disease
    Suades, Rosa
    Cosentino, Francesco
    Badimon, Lina
    CURRENT OPINION IN PHARMACOLOGY, 2018, 39 : 86 - 98
  • [2] LEADER and the new 'cardiovascular' glucose-lowering agents
    Livingstone, Rachel
    Boyle, James G.
    Petrie, John R.
    PRACTICAL DIABETES, 2016, 33 (06) : 187 - 189
  • [3] The impact of glucose-lowering medications on cardiovascular disease
    Avogaro, Angelo
    De Kreutzenberg, Saula Vigili
    Fadini, Gian Paolo
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2018, 7 (01): : 13 - 17
  • [4] Noninsulin glucose-lowering agents for the treatment of patients on dialysis
    Colleen Flynn
    George L. Bakris
    Nature Reviews Nephrology, 2013, 9 : 147 - 153
  • [5] New Glucose-Lowering Agents for Diabetic Kidney Disease
    de Vos, Lisanne C.
    Hettige, Thushan S.
    Cooper, Mark E.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2018, 25 (02) : 149 - 157
  • [6] Noninsulin glucose-lowering agents for the treatment of patients on dialysis
    Flynn, Colleen
    Bakris, George L.
    NATURE REVIEWS NEPHROLOGY, 2013, 9 (03) : 147 - 153
  • [7] Glucose-Lowering Medications and Cardiovascular Outcomes
    Madhan Shanmugasundaram
    J. R. Exequiel Pineda
    Sangeetha Murugapandian
    Current Cardiology Reports, 2021, 23
  • [8] Glucose-Lowering Medications and Cardiovascular Outcomes
    Shanmugasundaram, Madhan
    Pineda, J. R. Exequiel
    Murugapandian, Sangeetha
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (04)
  • [9] Effects of glucose-lowering agents on ischemic stroke
    Avgerinos, Konstantinos
    Tziomalos, Konstantinos
    WORLD JOURNAL OF DIABETES, 2017, 8 (06) : 270 - 277
  • [10] DRUG ERRORS INVOLVING GLUCOSE-LOWERING AGENTS
    Shaw, Sylvia J.
    Buglu, Stefan
    ENDOCRINE PRACTICE, 2010, 16 (01) : 134 - 135
12345